A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

NCT01793636 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

49

Enrollment

OTHER

Sponsor class

Stopped Inferior efficacy of study drug in renal indication.

Conditions

Metastatic Clear Cell Renal Carcinoma

Interventions

DRUG: AZD2014
DRUG: Everolimus

Sponsor

Queen Mary University of London

Collaborators

[object Object]
[object Object]